vs
Side-by-side financial comparison of Nutex Health, Inc. (NUTX) and Piedmont Realty Trust, Inc. (PDM). Click either name above to swap in a different company.
Nutex Health, Inc. is the larger business by last-quarter revenue ($151.7M vs $143.3M, roughly 1.1× Piedmont Realty Trust, Inc.). Nutex Health, Inc. runs the higher net margin — 7.8% vs -31.4%, a 39.2% gap on every dollar of revenue. On growth, Piedmont Realty Trust, Inc. posted the faster year-over-year revenue change (0.4% vs -41.1%). Over the past eight quarters, Nutex Health, Inc.'s revenue compounded faster (50.0% CAGR vs 0.0%).
Nutex Health Inc. is an American for-profit health care company and operator of healthcare facilities headquartered in Houston, Texas.
Piedmont Realty Trust, Inc. is a publicly traded real estate investment trust (REIT) that owns, operates, and invests in high-quality office properties primarily located in high-growth metropolitan areas across the United States. It serves corporate tenants across multiple industry sectors including technology, professional services, and healthcare, and pursues stable long-term returns for stakeholders via strategic property management and portfolio optimization.
NUTX vs PDM — Head-to-Head
Income Statement — Q4 FY2025 vs Q1 FY2026
| Metric | | |
|---|---|---|
| Revenue | $151.7M | $143.3M |
| Net Profit | $11.8M | $-45.0M |
| Gross Margin | 30.4% | — |
| Operating Margin | 20.4% | — |
| Net Margin | 7.8% | -31.4% |
| Revenue YoY | -41.1% | 0.4% |
| Net Profit YoY | -80.8% | -27.9% |
| EPS (diluted) | $2.34 | $-0.10 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q1 26 | — | $143.3M | ||
| Q4 25 | $151.7M | $142.9M | ||
| Q3 25 | $267.8M | $139.2M | ||
| Q2 25 | $244.0M | $140.3M | ||
| Q1 25 | $211.8M | $142.7M | ||
| Q4 24 | $257.6M | $143.2M | ||
| Q3 24 | $78.8M | $139.3M | ||
| Q2 24 | $76.1M | $143.3M |
| Q1 26 | — | $-45.0M | ||
| Q4 25 | $11.8M | $-43.2M | ||
| Q3 25 | $55.4M | $-13.5M | ||
| Q2 25 | $-17.7M | $-16.8M | ||
| Q1 25 | $21.2M | $-10.1M | ||
| Q4 24 | $61.6M | $-30.0M | ||
| Q3 24 | $-8.8M | $-11.5M | ||
| Q2 24 | $-364.0K | $-9.8M |
| Q1 26 | — | — | ||
| Q4 25 | 30.4% | — | ||
| Q3 25 | 57.8% | — | ||
| Q2 25 | 51.2% | — | ||
| Q1 25 | 55.9% | — | ||
| Q4 24 | 55.0% | — | ||
| Q3 24 | 27.8% | — | ||
| Q2 24 | 29.7% | — |
| Q1 26 | — | — | ||
| Q4 25 | 20.4% | — | ||
| Q3 25 | 48.7% | — | ||
| Q2 25 | 13.8% | — | ||
| Q1 25 | 38.1% | — | ||
| Q4 24 | 44.4% | — | ||
| Q3 24 | 12.3% | — | ||
| Q2 24 | 7.0% | — |
| Q1 26 | — | -31.4% | ||
| Q4 25 | 7.8% | -30.3% | ||
| Q3 25 | 20.7% | -9.7% | ||
| Q2 25 | -7.3% | -12.0% | ||
| Q1 25 | 10.0% | -7.1% | ||
| Q4 24 | 23.9% | -20.9% | ||
| Q3 24 | -11.2% | -8.3% | ||
| Q2 24 | -0.5% | -6.8% |
| Q1 26 | — | $-0.10 | ||
| Q4 25 | $2.34 | $-0.34 | ||
| Q3 25 | $7.76 | $-0.11 | ||
| Q2 25 | $-2.95 | $-0.14 | ||
| Q1 25 | $3.33 | $-0.08 | ||
| Q4 24 | $11.56 | $-0.25 | ||
| Q3 24 | $-1.72 | $-0.09 | ||
| Q2 24 | $-0.07 | $-0.08 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $185.6M | $2.3M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $329.4M | $1.5B |
| Total Assets | $918.5M | $4.0B |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | $2.3M | ||
| Q4 25 | $185.6M | $731.0K | ||
| Q3 25 | $166.0M | $3.0M | ||
| Q2 25 | $96.7M | $3.3M | ||
| Q1 25 | $84.7M | $2.9M | ||
| Q4 24 | $40.6M | $109.6M | ||
| Q3 24 | $46.9M | $133.6M | ||
| Q2 24 | $40.8M | $138.5M |
| Q1 26 | — | — | ||
| Q4 25 | — | $2.2B | ||
| Q3 25 | — | $2.2B | ||
| Q2 25 | — | $2.2B | ||
| Q1 25 | — | $2.2B | ||
| Q4 24 | — | $2.2B | ||
| Q3 24 | — | $2.2B | ||
| Q2 24 | — | $2.2B |
| Q1 26 | — | $1.5B | ||
| Q4 25 | $329.4M | $1.5B | ||
| Q3 25 | $317.2M | $1.5B | ||
| Q2 25 | $235.3M | $1.5B | ||
| Q1 25 | $176.9M | $1.6B | ||
| Q4 24 | $132.4M | $1.6B | ||
| Q3 24 | $60.4M | $1.6B | ||
| Q2 24 | $62.7M | $1.7B |
| Q1 26 | — | $4.0B | ||
| Q4 25 | $918.5M | $4.0B | ||
| Q3 25 | $964.5M | $4.0B | ||
| Q2 25 | $841.0M | $4.0B | ||
| Q1 25 | $761.9M | $4.0B | ||
| Q4 24 | $655.3M | $4.1B | ||
| Q3 24 | $438.5M | $4.1B | ||
| Q2 24 | $422.4M | $4.2B |
| Q1 26 | — | — | ||
| Q4 25 | — | 1.49× | ||
| Q3 25 | — | 1.43× | ||
| Q2 25 | — | 1.41× | ||
| Q1 25 | — | 1.40× | ||
| Q4 24 | — | 1.40× | ||
| Q3 24 | — | 1.36× | ||
| Q2 24 | — | 1.34× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $70.4M | — |
| Free Cash FlowOCF − Capex | $69.0M | — |
| FCF MarginFCF / Revenue | 45.5% | — |
| Capex IntensityCapex / Revenue | 0.9% | 110.3% |
| Cash ConversionOCF / Net Profit | 5.95× | — |
| TTM Free Cash FlowTrailing 4 quarters | $245.6M | — |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | — | ||
| Q4 25 | $70.4M | $140.6M | ||
| Q3 25 | $99.5M | $35.8M | ||
| Q2 25 | $27.3M | $50.1M | ||
| Q1 25 | $51.0M | $3.7M | ||
| Q4 24 | $54.0K | $198.1M | ||
| Q3 24 | $6.8M | $42.9M | ||
| Q2 24 | $13.3M | $66.8M |
| Q1 26 | — | — | ||
| Q4 25 | $69.0M | — | ||
| Q3 25 | $99.2M | — | ||
| Q2 25 | $26.5M | — | ||
| Q1 25 | $50.9M | — | ||
| Q4 24 | $-341.0K | — | ||
| Q3 24 | $6.2M | — | ||
| Q2 24 | $12.7M | — |
| Q1 26 | — | — | ||
| Q4 25 | 45.5% | — | ||
| Q3 25 | 37.0% | — | ||
| Q2 25 | 10.9% | — | ||
| Q1 25 | 24.0% | — | ||
| Q4 24 | -0.1% | — | ||
| Q3 24 | 7.8% | — | ||
| Q2 24 | 16.7% | — |
| Q1 26 | — | 110.3% | ||
| Q4 25 | 0.9% | — | ||
| Q3 25 | 0.1% | — | ||
| Q2 25 | 0.3% | — | ||
| Q1 25 | 0.0% | — | ||
| Q4 24 | 0.2% | — | ||
| Q3 24 | 0.8% | — | ||
| Q2 24 | 0.7% | — |
| Q1 26 | — | — | ||
| Q4 25 | 5.95× | — | ||
| Q3 25 | 1.80× | — | ||
| Q2 25 | — | — | ||
| Q1 25 | 2.40× | — | ||
| Q4 24 | 0.00× | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
NUTX
| Hospital Division | $143.7M | 95% |
| Population Health Management Division | $8.0M | 5% |
PDM
Segment breakdown not available.
